NL1029596A1 - Nieuwe piperidylderivaten van chinazoline en isochinoline. - Google Patents
Nieuwe piperidylderivaten van chinazoline en isochinoline.Info
- Publication number
- NL1029596A1 NL1029596A1 NL1029596A NL1029596A NL1029596A1 NL 1029596 A1 NL1029596 A1 NL 1029596A1 NL 1029596 A NL1029596 A NL 1029596A NL 1029596 A NL1029596 A NL 1029596A NL 1029596 A1 NL1029596 A1 NL 1029596A1
- Authority
- NL
- Netherlands
- Prior art keywords
- chinazoline
- isoquinoline
- piperidyl derivatives
- new
- new piperidyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59094304P | 2004-07-23 | 2004-07-23 | |
US59094304 | 2004-07-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
NL1029596A1 true NL1029596A1 (nl) | 2006-01-24 |
NL1029596C2 NL1029596C2 (nl) | 2006-09-06 |
Family
ID=34972555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL1029596A NL1029596C2 (nl) | 2004-07-23 | 2005-07-22 | Nieuwe piperidylderivaten van chinazoline en isochinoline. |
Country Status (25)
Country | Link |
---|---|
US (1) | US20060019975A1 (nl) |
EP (1) | EP1773805A1 (nl) |
JP (1) | JP2008507500A (nl) |
CN (1) | CN1989124A (nl) |
AP (1) | AP2007003891A0 (nl) |
AR (1) | AR050433A1 (nl) |
AU (1) | AU2005266080A1 (nl) |
BR (1) | BRPI0513475A (nl) |
CA (1) | CA2574685A1 (nl) |
CR (1) | CR8861A (nl) |
EA (1) | EA200700097A1 (nl) |
EC (1) | ECSP077193A (nl) |
GT (1) | GT200500198A (nl) |
IL (1) | IL180205A0 (nl) |
MA (1) | MA28746B1 (nl) |
MX (1) | MX2007000878A (nl) |
NL (1) | NL1029596C2 (nl) |
NO (1) | NO20065948L (nl) |
PE (1) | PE20060570A1 (nl) |
SV (1) | SV2006002175A (nl) |
TN (1) | TNSN07021A1 (nl) |
TW (1) | TW200616641A (nl) |
UY (1) | UY29028A1 (nl) |
WO (1) | WO2006011040A1 (nl) |
ZA (1) | ZA200700223B (nl) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1796669B1 (en) * | 2004-10-01 | 2010-09-22 | Merck Sharp & Dohme Corp. | Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
US7700595B2 (en) * | 2005-03-01 | 2010-04-20 | Wyeth Llc | Cinnoline compounds |
JP2009524637A (ja) * | 2006-01-27 | 2009-07-02 | ファイザー・プロダクツ・インク | アミノフタラジン誘導体化合物 |
MX2008010671A (es) * | 2006-02-21 | 2008-10-01 | Amgen Inc | Derivados de cinolina como inhibidores de fosfodiesterasa 10. |
EP1991530A1 (en) * | 2006-02-21 | 2008-11-19 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
AU2007221049A1 (en) * | 2006-02-28 | 2007-09-07 | Amgen Inc. | Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
US20090099175A1 (en) * | 2006-03-01 | 2009-04-16 | Arrington Mark P | Phosphodiesterase 10 inhibitors |
US20070265258A1 (en) * | 2006-03-06 | 2007-11-15 | Ruiping Liu | Quinazoline derivatives as phosphodiesterase 10 inhibitors |
EP1996574A1 (en) * | 2006-03-08 | 2008-12-03 | Amgen Inc. | Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
EP1997812B1 (en) * | 2006-03-17 | 2011-07-13 | Mitsubishi Gas Chemical Company, Inc. | Method for production of quinazolin-4-on derivative |
JP2009542732A (ja) * | 2006-07-10 | 2009-12-03 | ハー・ルンドベック・アクチエゼルスカベット | 6,7−ジアルコキシキナゾリン、6,7−ジアルコキシフタラジンおよび6,7−ジアルコキシイソキノリンの(3−アリール−ピペラジン−1−イル)、(2−アリール−モルホリン−4−イル)および(2−アリール−チオモルホリン−4−イル)誘導体 |
EP1903037A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors |
EP1903038A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren |
WO2009025839A2 (en) * | 2007-08-22 | 2009-02-26 | Amgen Inc. | Phosphodiesterase 10 inhibitors |
TW200918519A (en) * | 2007-09-19 | 2009-05-01 | Lundbeck & Co As H | Cyanoisoquinoline |
US7858620B2 (en) * | 2007-09-19 | 2010-12-28 | H. Lundbeck A/S | Cyanoisoquinoline |
UA102693C2 (ru) | 2008-06-20 | 2013-08-12 | Х. Луннбек А/С | Производные фенилимидазола как ингибиторы фермента pde10a |
ES2397934T3 (es) | 2008-12-17 | 2013-03-12 | Amgen Inc. | Compuestos de aminopiridina y carboxipiridina como inhibidores de fosfodiesterasa 10 |
TW201200516A (en) | 2009-12-17 | 2012-01-01 | Lundbeck & Co As H | Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors |
TWI481607B (zh) | 2009-12-17 | 2015-04-21 | Lundbeck & Co As H | 作為pde10a酵素抑制劑的2-芳基咪唑衍生物 |
TWI485151B (zh) | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為pde10a酵素抑制劑之雜芳香族苯基咪唑衍生物 |
TWI487705B (zh) | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為pde10a酵素抑制劑之雜芳香族芳基三唑衍生物 |
MX2012013128A (es) | 2010-05-13 | 2013-03-20 | Amgen Inc | Compuestos heterociclicos de nitrogeno como inhibidores de la fosfodiesterasa 10. |
AU2011253058A1 (en) | 2010-05-13 | 2012-12-06 | Amgen Inc. | Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors |
AU2011253003B2 (en) | 2010-05-13 | 2014-05-01 | Amgen Inc. | Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors |
MX2012013130A (es) | 2010-05-13 | 2013-04-11 | Amgen Inc | Compuestos heterociclicos de nitrogeno utiles como inhibidores de pde10. |
TW201215607A (en) | 2010-07-02 | 2012-04-16 | Lundbeck & Co As H | Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor |
TW201206935A (en) | 2010-07-16 | 2012-02-16 | Lundbeck & Co As H | Triazolo-and pyrazoloquinazoline derivatives as PDE10A enzyme inhibitor |
DE102010042833B4 (de) | 2010-10-22 | 2018-11-08 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Neue Halogenalkoxychinazoline, deren Herstellung und Verwendung |
JO3089B1 (ar) | 2010-11-19 | 2017-03-15 | H Lundbeck As | مشتقات ايميدازول كمثبطات لانزيمات pde10a |
WO2012112946A1 (en) | 2011-02-18 | 2012-08-23 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
WO2013045607A1 (en) | 2011-09-30 | 2013-04-04 | H. Lundbeck A/S | Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors |
WO2013050527A1 (en) | 2011-10-05 | 2013-04-11 | H. Lundbeck A/S | Quinazoline derivatives as pde10a enzyme inhibitors |
AR089361A1 (es) | 2011-12-21 | 2014-08-20 | Lundbeck & Co As H | Derivados de quinolina como inhibidores de la enzima pde10a |
WO2013127817A1 (en) | 2012-02-27 | 2013-09-06 | H. Lundbeck A/S | Imidazole derivatives as pde10a enzyme inhibitors |
TW201348231A (zh) | 2012-02-29 | 2013-12-01 | Amgen Inc | 雜雙環化合物 |
KR101689093B1 (ko) | 2012-06-04 | 2016-12-22 | 액테리온 파마슈티칼 리미티드 | 벤즈이미다졸-프롤린 유도체 |
SG11201502493XA (en) | 2012-10-10 | 2015-04-29 | Actelion Pharmaceuticals Ltd | Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives |
WO2014071044A1 (en) | 2012-11-01 | 2014-05-08 | Allergan, Inc. | Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a) |
JP2016510810A (ja) | 2013-03-12 | 2016-04-11 | アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd | オレキシン受容体アンタゴニストとしてのアゼチジンアミド誘導体 |
TR201815342T4 (tr) | 2013-12-04 | 2018-11-21 | Idorsia Pharmaceuticals Ltd | Benzimidazol-prolin türevlerinin kullanımı. |
US9200016B2 (en) | 2013-12-05 | 2015-12-01 | Allergan, Inc. | Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) |
DK3126354T3 (da) * | 2014-04-04 | 2020-03-09 | H Lundbeck As | Halogenerede quinazolin-thf-aminer som pde1-inhibitorer |
CN106632089B (zh) * | 2016-11-04 | 2019-06-18 | 中山大学 | 一类喹唑啉类化合物及其制备方法与应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3517005A (en) * | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
IN148482B (nl) * | 1977-06-03 | 1981-03-07 | Pfizer | |
JPS60120872A (ja) * | 1983-12-01 | 1985-06-28 | Kyowa Hakko Kogyo Co Ltd | 新規なヘテロ環状化合物及び強心剤 |
US5721237A (en) * | 1991-05-10 | 1998-02-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
US5624926A (en) * | 1993-02-18 | 1997-04-29 | Kyowa Hakko Kogyo Co., Ltd. | Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors |
WO1995007267A1 (fr) * | 1993-09-10 | 1995-03-16 | Eisai Co., Ltd. | Compose de quinazoline |
JP3919272B2 (ja) * | 1996-12-18 | 2007-05-23 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | キナゾリン系化合物 |
US20030032579A1 (en) * | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
ATE402164T1 (de) * | 2001-04-26 | 2008-08-15 | Eisai R&D Man Co Ltd | Stickstoffhaltige verbindung mit kondensiertem ring und pyrazolylgruppe als substituent und medizinische zusammensetzung davon |
JP4782564B2 (ja) * | 2002-07-10 | 2011-09-28 | メルク セローノ ソシエテ アノニム | アゾリジノン−ビニル縮合−ベンゼン誘導体 |
-
2005
- 2005-07-08 US US11/178,104 patent/US20060019975A1/en not_active Abandoned
- 2005-07-11 AP AP2007003891A patent/AP2007003891A0/xx unknown
- 2005-07-11 BR BRPI0513475-7A patent/BRPI0513475A/pt not_active Application Discontinuation
- 2005-07-11 AU AU2005266080A patent/AU2005266080A1/en not_active Abandoned
- 2005-07-11 EP EP05759014A patent/EP1773805A1/en not_active Withdrawn
- 2005-07-11 CA CA002574685A patent/CA2574685A1/en not_active Abandoned
- 2005-07-11 MX MX2007000878A patent/MX2007000878A/es unknown
- 2005-07-11 CN CNA2005800248487A patent/CN1989124A/zh active Pending
- 2005-07-11 WO PCT/IB2005/002177 patent/WO2006011040A1/en active Application Filing
- 2005-07-11 EA EA200700097A patent/EA200700097A1/ru unknown
- 2005-07-11 JP JP2007522057A patent/JP2008507500A/ja not_active Withdrawn
- 2005-07-20 PE PE2005000840A patent/PE20060570A1/es not_active Application Discontinuation
- 2005-07-21 UY UY29028A patent/UY29028A1/es not_active Application Discontinuation
- 2005-07-21 AR ARP050103018A patent/AR050433A1/es unknown
- 2005-07-21 GT GT200500198A patent/GT200500198A/es unknown
- 2005-07-22 NL NL1029596A patent/NL1029596C2/nl not_active IP Right Cessation
- 2005-07-22 SV SV2005002175A patent/SV2006002175A/es not_active Application Discontinuation
- 2005-07-22 TW TW094124808A patent/TW200616641A/zh unknown
-
2006
- 2006-12-20 IL IL180205A patent/IL180205A0/en unknown
- 2006-12-21 NO NO20065948A patent/NO20065948L/no not_active Application Discontinuation
-
2007
- 2007-01-08 ZA ZA200700223A patent/ZA200700223B/xx unknown
- 2007-01-18 CR CR8861A patent/CR8861A/es not_active Application Discontinuation
- 2007-01-22 TN TNP2007000021A patent/TNSN07021A1/fr unknown
- 2007-01-23 MA MA29625A patent/MA28746B1/fr unknown
- 2007-01-23 EC EC2007007193A patent/ECSP077193A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200700223B (en) | 2008-08-27 |
GT200500198A (es) | 2006-03-02 |
TNSN07021A1 (fr) | 2008-06-02 |
IL180205A0 (en) | 2007-07-04 |
EA200700097A1 (ru) | 2007-06-29 |
NO20065948L (no) | 2007-01-23 |
CN1989124A (zh) | 2007-06-27 |
CR8861A (es) | 2007-03-02 |
WO2006011040A1 (en) | 2006-02-02 |
JP2008507500A (ja) | 2008-03-13 |
TW200616641A (en) | 2006-06-01 |
NL1029596C2 (nl) | 2006-09-06 |
AP2007003891A0 (en) | 2007-02-28 |
MX2007000878A (es) | 2007-03-12 |
ECSP077193A (es) | 2007-02-28 |
BRPI0513475A (pt) | 2008-05-06 |
CA2574685A1 (en) | 2006-02-02 |
EP1773805A1 (en) | 2007-04-18 |
AU2005266080A1 (en) | 2006-02-02 |
PE20060570A1 (es) | 2006-07-14 |
AR050433A1 (es) | 2006-10-25 |
SV2006002175A (es) | 2006-02-15 |
MA28746B1 (fr) | 2007-07-02 |
UY29028A1 (es) | 2006-02-24 |
US20060019975A1 (en) | 2006-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL1029596A1 (nl) | Nieuwe piperidylderivaten van chinazoline en isochinoline. | |
NL1028321A1 (nl) | Tetrahydro-isochinolinylderivaten van chinazoline en isochinoline. | |
NL350092I2 (nl) | Combinatie van bixafen en fluoxastrobine | |
DE602007010981D1 (de) | Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate | |
IL177650A0 (en) | Isoquinoline derivatives and methods of use thereof | |
IS8439A (is) | Nýjar kínólín afleiður | |
AP2507A (en) | Quinoline derivatives and use thereof as mycobacterial inhibitors. | |
DK1928457T3 (da) | Quinoliner og deres terapeutiske anvendelse | |
MA29039B1 (fr) | Dibenzylamines et derives | |
ATE413389T1 (de) | Chinazolinderivate | |
ATE423121T1 (de) | Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren | |
DE602004004553D1 (de) | Chinazolinderivate | |
DE602004022180D1 (de) | Chinazolinderivate | |
DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
DK1675852T3 (da) | Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner | |
DK1828137T3 (da) | 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter | |
NL1029139A1 (nl) | Nieuwe aminopyridinederivaten en hun gebruik als farmaceutica. | |
ATE460415T1 (de) | Therapeutische pyrazoloä3,4-büpyridine und - indazole | |
DK1791872T3 (da) | Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf | |
FI20041220A0 (fi) | Uusi lakkaasientsyymi ja sen käyttö | |
FI20045252A0 (fi) | AV-järjestely sekä ohjain | |
ZA200802683B (en) | Quinolines and their therapeutic use | |
ES1059242Y (es) | Expositor de joyas y bisuteria. | |
SE0400029D0 (sv) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
SE0400031D0 (sv) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AD1A | A request for search or an international type search has been filed | ||
RD2N | Patents in respect of which a decision has been taken or a report has been made (novelty report) |
Effective date: 20060428 |
|
PD2B | A search report has been drawn up | ||
VD1 | Lapsed due to non-payment of the annual fee |
Effective date: 20090201 |